ZHONGSHEN, China, 26 August 2024 /PRNewswire/ — Meihua International Medical Technologies Co., Ltd. (“MHUA” or the “Company”) (Nasdaq: MHUA), a renowned manufacturer and supplier of Class I, II and III disposable medical devices with operating subsidiaries in Chinaannounced today that Xin “Steven” Wang, Chief Executive Officer of Meihua, will present and discuss current corporate events at LIVE! with Webull Corporate Connect: Healthcare Investment Virtual Webinar on Wednesday, August 28, 2024at 3:00 p.m. ET.
Conference details:
Conference: LIVE! with Webull Corporate Connect: Virtual Webinar on Healthcare Investments
Date/Time: Wednesday, August 28, 2024at 3:00 p.m. ET
Moderator: Xin “Steven” Wang, CEO of Meihua
Registration link: https://us02web.zoom.us/webinar/register/WN_E-VdYojiQ9eGpDCKB3lz2g
About Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies is a renowned manufacturer and supplier of Class I, II and III disposable medical products with operating subsidiaries in China. The company manufactures and sells Class I disposable medical products, such as HDPE bottles for tablets and LDPE bottles for eye drops, throat strips and anal bags, as well as Class II and III disposable medical products, such as disposable identification bracelets, gynecological examination kits, inspection kits, surgical kits, medical brushes, medical dressings, medical catheters, uterine tissue suction tables, virus sample tubes, disposable infusion pumps, electronic pumps and anesthesia puncture kits, among other products sold under Meihua’s own brands and also purchased and sold from other manufacturers. The company has obtained international “CE” certification and ISO 13485 system certification, and is also registered with FDA (registration number: 3006554788) for more than 20 Class I products. The company has been supplying hospitals, pharmacies, medical institutions and medical equipment manufacturers for more than 30 years, offering over 1,000 types of products for domestic sales and more than 120 products exported to more than 30 countries worldwide. Europe, North America, South America, Asia, Africa and Oceania.
For more information, visit www.meihuamed.com.
Follow us on Webull: https://www.webull.com/quote/nasdaq-mhua.
About Webull
Webull Financial LLC (“Webull Financial”) is a leading online brokerage platform dedicated to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of assets, advanced charting tools, and real-time market data, Webull Financial is revolutionizing the way individuals approach investing. Its user-centric approach and commitment to staying at the forefront of industry trends underscore its mission to provide a seamless and rewarding experience for traders of all levels. Through the Webull Group, Webull Financial and its subsidiaries collectively serve tens of millions of users from over 180 countries worldwide. Securities and futures trading is offered to clients of Webull Financial, a broker-dealer registered with the Securities and Exchange Commission (SEC) and a futures commission dealer registered with the Commodity Futures Trading Commission (CFTC). Webull Financial is also a member of the Financial Industry Authority (FINRA), the National Futures Association (NFA), and the Securities Investor Protection Corporation (SIPC). Webull Financial’s holding company, Webull Corporation, is a Cayman Islands Companies based in St. Petersburg, FLand owned by a diverse group of investors from the United States, EuropeAnd Asia. Any investment involves risk, including the possible loss of principal invested. For more information about Webull, visit www.webull.com.
Forward-looking statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding plans, objectives, strategies, future events or performance and underlying assumptions and other statements that are not historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not refer solely to historical matters, they are forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that could cause actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the Company’s ability to achieve its objectives and strategies, the Company’s future business performance and plans for future business development, including its ability to successfully develop robotic surgery systems and obtain licenses and certifications for such systems, financial condition and results of operations, demand for and acceptance of products and services, reputation and brand, the impact of competition and pricing, technological changes, government regulations, fluctuations in general economic and business conditions in Chinaand assumptions underlying or related to the foregoing and other risks included in the Company’s reports filed with the SEC. For these and other reasons, investors are cautioned not to place undue reliance on the forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, including in the “Risk Factors” section of its Annual Report on Form 20-F and Form 6-K and other filings, all of which are available at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that occur after the date of this release.
For investor and media inquiries please contact:
IR Department
E-mail: (email protected)
Phone: +86-0514-89800199
Christensen
Dee Wang
E-mail: (email protected)
Phone: +86-010-59001548
